arrow_back Back Filing freshness 10-Q Q2 FY2026 SEC EDGAR

BALCHEM CORP

BCPC
$179.34 ▼ -1.10 (-0.61%) at close
Materials ·Chemicals & Allied Products ·USChemicals & Allied Products
68 Visible periods
31 Metrics
Peer-ranked Benchmarks
Price Chart
79
Health
Good
Bullish
auto_awesome

Analytical Summary

BALCHEM CORP shows strong fundamentals with top-quartile Operating Margin (%). The company's metrics support a bullish outlook for growth-oriented investors.

Market Cap $5.7B
Dividend Yield
Revenue Growth 11.2%
Op. Margin 20.9%
ROIC 3.6%
FCF / Share $1.46
Trailing P/E 128.1x
Price / Book 4.4x
FCF Yield 0.8%
Debt / Equity
info Valuation on last close. End-of-day price, Aug 7, 2026.

68-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$284.00M
↑ +11.2%
Net Income Profit after all expenses
$40.28M
↑ +8.7%
Operating Margin Operating profit as % of sales
20.9%
↑ +1.5% 75th
FCF / Share Free cash flow per share
$1.46
↑ +16.7%
Long-Term Debt Long-term obligations
$0.00
trending_up

Bullish Indicators

  • Operating Margin (%)Operating Margin (%) is in the top quartile
warning

Bearish Risks

  • No bearish risks detected.

Health Breakdown

Profitability
78
Returns
74
Financial Health
88
Cash Quality
78

Dividend History

Dividend / share · sourced from SEC filings
$0.96 Latest / share
+10.3% YoY
+10.2% 3-yr CAGR

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 18 years · 68 quarters